{
  "url": "https://openlegislation.uk/eu-regulation-2016-429/article-7",
  "json_url": "https://openlegislation.uk/eu-regulation-2016-429/article-7.json",
  "legislation": "eur/2016/429",
  "legislation_title": "Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2016-429",
  "path": "article/7",
  "kind": "article",
  "number": "7",
  "heading": "Assessment parameters for the listing of diseases",
  "text": "The Commission shall use the following assessment parameters in order to determine whether a disease meets the conditions requiring it to be listed in accordance with Article 5(2):\n(a) the disease profile, which shall comprise the following:\n(i) the animal species concerned by the disease;\n(ii) the morbidity and mortality rates of the disease in animal populations;\n(iii) the zoonotic character of the disease;\n(iv) the resistance to treatments, including antimicrobial resistance;\n(v) the persistence of the disease in an animal population or in the environment;\n(vi) the routes and speed of transmission of the disease between animals and, when relevant, between animals and humans;\n(vii) the absence or presence and distribution of the disease in the Union, and, where the disease is not present in the Union, the risk of its introduction into the Union;\n(viii) the existence of diagnostic and disease control tools;\n(b) the impact of the disease on:\n(i) agricultural and aquaculture production and other parts of the economy, as regards:\nthe level of presence of the disease in the Union;\nthe loss of production due to the disease;\nother losses;\n(ii) human health, as regards:\ntransmissibility between animals and humans;\ntransmissibility between humans;\nthe severity of human forms of the disease;\nthe availability of effective prevention or medical treatment in humans;\n(iii) animal welfare;\n(iv) biodiversity and the environment;\n(c) its potential to generate a crisis situation and its potential use in bioterrorism;\n(d) the feasibility, availability and effectiveness of the following disease prevention and control measures:\n(i) diagnostic tools and capacities;\n(ii) vaccination;\n(iii) medical treatments;\n(iv) biosecurity measures;\n(v) restrictions on the movement of animals and products;\n(vi) killing of animals;\n(vii) disposal of carcasses and other relevant animal by–products;\n(e) the impact of disease prevention and control measures, as regards:\n(i) the direct and indirect costs for the affected sectors and the economy as a whole;\n(ii) their societal acceptance;\n(iii) the welfare of affected subpopulations of kept and wild animals;\n(iv) the environment and biodiversity.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2016/429/article/7",
    "retrieved_at": "2026-11-01T14:45:57.045484+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}